Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma

Published:2017-06-15 Issue:30 Volume:8 Page:50023-50033
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Zhiguo¹,Zhu Rujian²³,Zheng Jiayi⁴,Chen Chen²,Huang Chi²,Ma Junjie²,Xu Chen¹,Zhai Wei¹⁵,Zheng Junhua¹

Affiliation:

1. Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China

2. Department of Urology, The Affiliated Shanghai Tenth People's Hospital, Nanjing Medical University, Shanghai, China

3. Department of Urology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China

4. Department of Pathology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China

5. Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies;Biomolecules;2024-02-07

2. Diterpenoid Tanshinones Can Inhibit Lung Cancer Progression by Improving the Tumor Microenvironment and Downregulation of NF-κB Expression;ACS Omega;2024-02-02

3. Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation;Biomedicine & Pharmacotherapy;2024-01

4. Prospective pharmacological potential of cryptotanshinone in cancer therapy;Pharmacological Research - Modern Chinese Medicine;2023-12

5. Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy;Cancers;2023-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3